Orbis Medicines ApS
42715646ActiveOrbis Medicines develops oral macrocycle drugs using an AI-powered platform.
Yleiskatsaus
- 31
- Työntekijät
- Tuntematon
- Liikevaihto
- 2021
- Perustettu
Avainpäättäjät
Oliver Horlacher
VP, AI & Computational Drug Design
João Ribas
Observer
Vanessa Carle
Observer
Marco Boorsma
Board Member
+20 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Orbis Medicines is a biotechnology company based in Copenhagen, Denmark, focused on revolutionizing drug discovery through its proprietary n Gen platform. The company specializes in the development of oral macrocycle drugs, known as n Cycles, which aim to provide orally bioavailable alternatives to...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- APS
- ALV-numero
- DK42715646
Päättäjät
24 yhteystietoa FunnelfeedrissäOliver Horlacher
VP, AI & Computational Drug Design
João Ribas
Observer
Vanessa Carle
Observer
Marco Boorsma
Board Member
Paul Cox
VP, Platform Chemistry
Alonso Ricardo
Board Member
Morten Graugaard
Chief Executive Officer and Board Member
Søren Møller
Board Member
Bihua Chen
Observer
Mikael Dolsten
Chairman of the Board
Mikkel Dybkjær
Chief Financial Officer / Chief Operating Officer
Pulkit Gupta
Observer
Lena Tagmose
Chief Technology Officer, Early Discovery and Platform Technologies
Mikkel Harndahl
VP, Discovery Biology & Operations
Edward Mathers
Board Member
James Buxton
Observer
Mads Lacoppidan
Observer
Daniel Greve
VP, Drug Discovery
Malene Bertelsen
VP, Translational Biology
Simon Feldbæk
Chief Development Officer
Muut yhteyshenkilöt
Marie Louise Gram
Scientist, Platform Chemistry
Rasmus Bøker Christensen
Principal Research Associate, DMPK
Marina Rode Von Essen
Senior Scientist, Translational Biology
Zander Harteveld
Principal Scientist, AI & Data Scientist
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäAbzu ApS
6 työntekijätAbzu uses explainable AI to develop safer RNA therapeutics.
Draupnir Bio ApS
8 työntekijätPioneering oral small molecule degraders for extracellular disease proteins.
Skape Bio ApS
12 työntekijätAI-driven biotechnology company designing novel miniproteins for GPCR drug discovery.
OmicVision Biosciences ApS
16 työntekijätOmicVision provides single-cell spatial proteomics to advance precision medicine.
Evaxion A/S
40 työntekijätAI-driven TechBio company developing personalized vaccines for cancer and infections.
Selaa lisää
Kysymyksiä yrityksestä Orbis Medicines ApS
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo